Report cover image

Global Neurofilament Protein Market Outlook and Growth Opportunities 2025

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 193 Pages
SKU # APRC20360851

Description

Summary

According to APO Research, the global Neurofilament Protein market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Neurofilament Protein is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % from 2025 through 2031.

The Asia-Pacific market for Neurofilament Protein is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Neurofilament Protein market is expected to rise from $ million to $ million by 2031, at a CAGR of I% from 2025 through 2031.

The Europe market for Neurofilament Protein is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Neurofilament Protein market include Merck, Sigma Aldrich Biotechnology, Rockland Immunochemicals, OriGene Technologies, EnCor Biotechnology, Cell Signaling Technology, Bio-Rad Laboratories and BioLegend, etc. In 2024, the top three vendors accounted for approximately % of the market revenue.

This report presents an overview of global market for Neurofilament Protein, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Neurofilament Protein, also provides the value of main regions and countries. Of the upcoming market potential for Neurofilament Protein, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Neurofilament Protein revenue, market share and industry ranking of main companies, data from 2020 to 2025. Identification of the major stakeholders in the global Neurofilament Protein market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global Neurofilament Protein company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
Neurofilament Protein Segment by Company

Merck
Sigma Aldrich Biotechnology
Rockland Immunochemicals
OriGene Technologies
EnCor Biotechnology
Cell Signaling Technology
Bio-Rad Laboratories
BioLegend
Neurofilament Protein Segment by Type

Neurofilament Protein H
Neurofilament Protein L
Neurofilament Protein M
Neurofilament Protein Segment by Application

Medical Care
Research
Other
Neurofilament Protein Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Neurofilament Protein status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Neurofilament Protein key companies, revenue, market share, and recent developments.
3. To split the Neurofilament Protein breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Neurofilament Protein market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Neurofilament Protein significant trends, drivers, influence factors in global and regions.
6. To analyze Neurofilament Protein competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neurofilament Protein market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Neurofilament Protein and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neurofilament Protein.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Neurofilament Protein industry.
Chapter 3: Detailed analysis of Neurofilament Protein company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Neurofilament Protein in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Neurofilament Protein in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.

Table of Contents

193 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Neurofilament Protein Market Size, 2020 VS 2024 VS 2031
1.3 Global Neurofilament Protein Market Size (2020-2031)
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Neurofilament Protein Market Dynamics
2.1 Neurofilament Protein Industry Trends
2.2 Neurofilament Protein Industry Drivers
2.3 Neurofilament Protein Industry Opportunities and Challenges
2.4 Neurofilament Protein Industry Restraints
3 Neurofilament Protein Market by Company
3.1 Global Neurofilament Protein Company Revenue Ranking in 2024
3.2 Global Neurofilament Protein Revenue by Company (2020-2025)
3.3 Global Neurofilament Protein Company Ranking (2023-2025)
3.4 Global Neurofilament Protein Company Manufacturing Base and Headquarters
3.5 Global Neurofilament Protein Company Product Type and Application
3.6 Global Neurofilament Protein Company Establishment Date
3.7 Market Competitive Analysis
3.7.1 Global Neurofilament Protein Market Concentration Ratio (CR5 and HHI)
3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.7.3 2024 Neurofilament Protein Tier 1, Tier 2, and Tier 3 Companies
3.8 Mergers and Acquisitions Expansion
4 Neurofilament Protein Market by Type
4.1 Neurofilament Protein Type Introduction
4.1.1 Neurofilament Protein H
4.1.2 Neurofilament Protein L
4.1.3 Neurofilament Protein M
4.2 Global Neurofilament Protein Sales Value by Type
4.2.1 Global Neurofilament Protein Sales Value by Type (2020 VS 2024 VS 2031)
4.2.2 Global Neurofilament Protein Sales Value by Type (2020-2031)
4.2.3 Global Neurofilament Protein Sales Value Share by Type (2020-2031)
5 Neurofilament Protein Market by Application
5.1 Neurofilament Protein Application Introduction
5.1.1 Medical Care
5.1.2 Research
5.1.3 Other
5.2 Global Neurofilament Protein Sales Value by Application
5.2.1 Global Neurofilament Protein Sales Value by Application (2020 VS 2024 VS 2031)
5.2.2 Global Neurofilament Protein Sales Value by Application (2020-2031)
5.2.3 Global Neurofilament Protein Sales Value Share by Application (2020-2031)
6 Neurofilament Protein Regional Value Analysis
6.1 Global Neurofilament Protein Sales Value by Region: 2020 VS 2024 VS 2031
6.2 Global Neurofilament Protein Sales Value by Region (2020-2031)
6.2.1 Global Neurofilament Protein Sales Value by Region: 2020-2025
6.2.2 Global Neurofilament Protein Sales Value by Region (2026-2031)
6.3 North America
6.3.1 North America Neurofilament Protein Sales Value (2020-2031)
6.3.2 North America Neurofilament Protein Sales Value Share by Country, 2024 VS 2031
6.4 Europe
6.4.1 Europe Neurofilament Protein Sales Value (2020-2031)
6.4.2 Europe Neurofilament Protein Sales Value Share by Country, 2024 VS 2031
6.5 Asia-Pacific
6.5.1 Asia-Pacific Neurofilament Protein Sales Value (2020-2031)
6.5.2 Asia-Pacific Neurofilament Protein Sales Value Share by Country, 2024 VS 2031
6.6 South America
6.6.1 South America Neurofilament Protein Sales Value (2020-2031)
6.6.2 South America Neurofilament Protein Sales Value Share by Country, 2024 VS 2031
6.7 Middle East & Africa
6.7.1 Middle East & Africa Neurofilament Protein Sales Value (2020-2031)
6.7.2 Middle East & Africa Neurofilament Protein Sales Value Share by Country, 2024 VS 2031
7 Neurofilament Protein Country-level Value Analysis
7.1 Global Neurofilament Protein Sales Value by Country: 2020 VS 2024 VS 2031
7.2 Global Neurofilament Protein Sales Value by Country (2020-2031)
7.2.1 Global Neurofilament Protein Sales Value by Country (2020-2025)
7.2.2 Global Neurofilament Protein Sales Value by Country (2026-2031)
7.3 USA
7.3.1 USA Neurofilament Protein Sales Value Growth Rate (2020-2031)
7.3.2 USA Neurofilament Protein Sales Value Share by Type, 2024 VS 2031
7.3.3 USA Neurofilament Protein Sales Value Share by Application, 2024 VS 2031
7.4 Canada
7.4.1 Canada Neurofilament Protein Sales Value Growth Rate (2020-2031)
7.4.2 Canada Neurofilament Protein Sales Value Share by Type, 2024 VS 2031
7.4.3 Canada Neurofilament Protein Sales Value Share by Application, 2024 VS 2031
7.5 Mexico
7.5.1 Mexico Neurofilament Protein Sales Value Growth Rate (2020-2031)
7.5.2 Mexico Neurofilament Protein Sales Value Share by Type, 2024 VS 2031
7.5.3 Mexico Neurofilament Protein Sales Value Share by Application, 2024 VS 2031
7.6 Germany
7.6.1 Germany Neurofilament Protein Sales Value Growth Rate (2020-2031)
7.6.2 Germany Neurofilament Protein Sales Value Share by Type, 2024 VS 2031
7.6.3 Germany Neurofilament Protein Sales Value Share by Application, 2024 VS 2031
7.7 France
7.7.1 France Neurofilament Protein Sales Value Growth Rate (2020-2031)
7.7.2 France Neurofilament Protein Sales Value Share by Type, 2024 VS 2031
7.7.3 France Neurofilament Protein Sales Value Share by Application, 2024 VS 2031
7.8 U.K.
7.8.1 U.K. Neurofilament Protein Sales Value Growth Rate (2020-2031)
7.8.2 U.K. Neurofilament Protein Sales Value Share by Type, 2024 VS 2031
7.8.3 U.K. Neurofilament Protein Sales Value Share by Application, 2024 VS 2031
7.9 Italy
7.9.1 Italy Neurofilament Protein Sales Value Growth Rate (2020-2031)
7.9.2 Italy Neurofilament Protein Sales Value Share by Type, 2024 VS 2031
7.9.3 Italy Neurofilament Protein Sales Value Share by Application, 2024 VS 2031
7.10 Spain
7.10.1 Spain Neurofilament Protein Sales Value Growth Rate (2020-2031)
7.10.2 Spain Neurofilament Protein Sales Value Share by Type, 2024 VS 2031
7.10.3 Spain Neurofilament Protein Sales Value Share by Application, 2024 VS 2031
7.11 Russia
7.11.1 Russia Neurofilament Protein Sales Value Growth Rate (2020-2031)
7.11.2 Russia Neurofilament Protein Sales Value Share by Type, 2024 VS 2031
7.11.3 Russia Neurofilament Protein Sales Value Share by Application, 2024 VS 2031
7.12 Netherlands
7.12.1 Netherlands Neurofilament Protein Sales Value Growth Rate (2020-2031)
7.12.2 Netherlands Neurofilament Protein Sales Value Share by Type, 2024 VS 2031
7.12.3 Netherlands Neurofilament Protein Sales Value Share by Application, 2024 VS 2031
7.13 Nordic Countries
7.13.1 Nordic Countries Neurofilament Protein Sales Value Growth Rate (2020-2031)
7.13.2 Nordic Countries Neurofilament Protein Sales Value Share by Type, 2024 VS 2031
7.13.3 Nordic Countries Neurofilament Protein Sales Value Share by Application, 2024 VS 2031
7.14 China
7.14.1 China Neurofilament Protein Sales Value Growth Rate (2020-2031)
7.14.2 China Neurofilament Protein Sales Value Share by Type, 2024 VS 2031
7.14.3 China Neurofilament Protein Sales Value Share by Application, 2024 VS 2031
7.15 Japan
7.15.1 Japan Neurofilament Protein Sales Value Growth Rate (2020-2031)
7.15.2 Japan Neurofilament Protein Sales Value Share by Type, 2024 VS 2031
7.15.3 Japan Neurofilament Protein Sales Value Share by Application, 2024 VS 2031
7.16 South Korea
7.16.1 South Korea Neurofilament Protein Sales Value Growth Rate (2020-2031)
7.16.2 South Korea Neurofilament Protein Sales Value Share by Type, 2024 VS 2031
7.16.3 South Korea Neurofilament Protein Sales Value Share by Application, 2024 VS 2031
7.17 India
7.17.1 India Neurofilament Protein Sales Value Growth Rate (2020-2031)
7.17.2 India Neurofilament Protein Sales Value Share by Type, 2024 VS 2031
7.17.3 India Neurofilament Protein Sales Value Share by Application, 2024 VS 2031
7.18 Australia
7.18.1 Australia Neurofilament Protein Sales Value Growth Rate (2020-2031)
7.18.2 Australia Neurofilament Protein Sales Value Share by Type, 2024 VS 2031
7.18.3 Australia Neurofilament Protein Sales Value Share by Application, 2024 VS 2031
7.19 Southeast Asia
7.19.1 Southeast Asia Neurofilament Protein Sales Value Growth Rate (2020-2031)
7.19.2 Southeast Asia Neurofilament Protein Sales Value Share by Type, 2024 VS 2031
7.19.3 Southeast Asia Neurofilament Protein Sales Value Share by Application, 2024 VS 2031
7.20 Brazil
7.20.1 Brazil Neurofilament Protein Sales Value Growth Rate (2020-2031)
7.20.2 Brazil Neurofilament Protein Sales Value Share by Type, 2024 VS 2031
7.20.3 Brazil Neurofilament Protein Sales Value Share by Application, 2024 VS 2031
7.21 Argentina
7.21.1 Argentina Neurofilament Protein Sales Value Growth Rate (2020-2031)
7.21.2 Argentina Neurofilament Protein Sales Value Share by Type, 2024 VS 2031
7.21.3 Argentina Neurofilament Protein Sales Value Share by Application, 2024 VS 2031
7.22 Chile
7.22.1 Chile Neurofilament Protein Sales Value Growth Rate (2020-2031)
7.22.2 Chile Neurofilament Protein Sales Value Share by Type, 2024 VS 2031
7.22.3 Chile Neurofilament Protein Sales Value Share by Application, 2024 VS 2031
7.23 Colombia
7.23.1 Colombia Neurofilament Protein Sales Value Growth Rate (2020-2031)
7.23.2 Colombia Neurofilament Protein Sales Value Share by Type, 2024 VS 2031
7.23.3 Colombia Neurofilament Protein Sales Value Share by Application, 2024 VS 2031
7.24 Peru
7.24.1 Peru Neurofilament Protein Sales Value Growth Rate (2020-2031)
7.24.2 Peru Neurofilament Protein Sales Value Share by Type, 2024 VS 2031
7.24.3 Peru Neurofilament Protein Sales Value Share by Application, 2024 VS 2031
7.25 Saudi Arabia
7.25.1 Saudi Arabia Neurofilament Protein Sales Value Growth Rate (2020-2031)
7.25.2 Saudi Arabia Neurofilament Protein Sales Value Share by Type, 2024 VS 2031
7.25.3 Saudi Arabia Neurofilament Protein Sales Value Share by Application, 2024 VS 2031
7.26 Israel
7.26.1 Israel Neurofilament Protein Sales Value Growth Rate (2020-2031)
7.26.2 Israel Neurofilament Protein Sales Value Share by Type, 2024 VS 2031
7.26.3 Israel Neurofilament Protein Sales Value Share by Application, 2024 VS 2031
7.27 UAE
7.27.1 UAE Neurofilament Protein Sales Value Growth Rate (2020-2031)
7.27.2 UAE Neurofilament Protein Sales Value Share by Type, 2024 VS 2031
7.27.3 UAE Neurofilament Protein Sales Value Share by Application, 2024 VS 2031
7.28 Turkey
7.28.1 Turkey Neurofilament Protein Sales Value Growth Rate (2020-2031)
7.28.2 Turkey Neurofilament Protein Sales Value Share by Type, 2024 VS 2031
7.28.3 Turkey Neurofilament Protein Sales Value Share by Application, 2024 VS 2031
7.29 Iran
7.29.1 Iran Neurofilament Protein Sales Value Growth Rate (2020-2031)
7.29.2 Iran Neurofilament Protein Sales Value Share by Type, 2024 VS 2031
7.29.3 Iran Neurofilament Protein Sales Value Share by Application, 2024 VS 2031
7.30 Egypt
7.30.1 Egypt Neurofilament Protein Sales Value Growth Rate (2020-2031)
7.30.2 Egypt Neurofilament Protein Sales Value Share by Type, 2024 VS 2031
7.30.3 Egypt Neurofilament Protein Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 Merck
8.1.1 Merck Comapny Information
8.1.2 Merck Business Overview
8.1.3 Merck Neurofilament Protein Revenue and Gross Margin (2020-2025)
8.1.4 Merck Neurofilament Protein Product Portfolio
8.1.5 Merck Recent Developments
8.2 Sigma Aldrich Biotechnology
8.2.1 Sigma Aldrich Biotechnology Comapny Information
8.2.2 Sigma Aldrich Biotechnology Business Overview
8.2.3 Sigma Aldrich Biotechnology Neurofilament Protein Revenue and Gross Margin (2020-2025)
8.2.4 Sigma Aldrich Biotechnology Neurofilament Protein Product Portfolio
8.2.5 Sigma Aldrich Biotechnology Recent Developments
8.3 Rockland Immunochemicals
8.3.1 Rockland Immunochemicals Comapny Information
8.3.2 Rockland Immunochemicals Business Overview
8.3.3 Rockland Immunochemicals Neurofilament Protein Revenue and Gross Margin (2020-2025)
8.3.4 Rockland Immunochemicals Neurofilament Protein Product Portfolio
8.3.5 Rockland Immunochemicals Recent Developments
8.4 OriGene Technologies
8.4.1 OriGene Technologies Comapny Information
8.4.2 OriGene Technologies Business Overview
8.4.3 OriGene Technologies Neurofilament Protein Revenue and Gross Margin (2020-2025)
8.4.4 OriGene Technologies Neurofilament Protein Product Portfolio
8.4.5 OriGene Technologies Recent Developments
8.5 EnCor Biotechnology
8.5.1 EnCor Biotechnology Comapny Information
8.5.2 EnCor Biotechnology Business Overview
8.5.3 EnCor Biotechnology Neurofilament Protein Revenue and Gross Margin (2020-2025)
8.5.4 EnCor Biotechnology Neurofilament Protein Product Portfolio
8.5.5 EnCor Biotechnology Recent Developments
8.6 Cell Signaling Technology
8.6.1 Cell Signaling Technology Comapny Information
8.6.2 Cell Signaling Technology Business Overview
8.6.3 Cell Signaling Technology Neurofilament Protein Revenue and Gross Margin (2020-2025)
8.6.4 Cell Signaling Technology Neurofilament Protein Product Portfolio
8.6.5 Cell Signaling Technology Recent Developments
8.7 Bio-Rad Laboratories
8.7.1 Bio-Rad Laboratories Comapny Information
8.7.2 Bio-Rad Laboratories Business Overview
8.7.3 Bio-Rad Laboratories Neurofilament Protein Revenue and Gross Margin (2020-2025)
8.7.4 Bio-Rad Laboratories Neurofilament Protein Product Portfolio
8.7.5 Bio-Rad Laboratories Recent Developments
8.8 BioLegend
8.8.1 BioLegend Comapny Information
8.8.2 BioLegend Business Overview
8.8.3 BioLegend Neurofilament Protein Revenue and Gross Margin (2020-2025)
8.8.4 BioLegend Neurofilament Protein Product Portfolio
8.8.5 BioLegend Recent Developments
9 Concluding Insights
10 Appendix
10.1 Reasons for Doing This Study
10.2 Research Methodology
10.3 Research Process
10.4 Authors List of This Report
10.5 Data Source
10.5.1 Secondary Sources
10.5.2 Primary Sources
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.